文献速递血栓与止血

雌激素上调乳铁蛋白诱导妊娠期高凝状态以保护止血

Estrogen upregulates lactoferrin to induce hypercoagulability for hemostatic protection during pregnancy.
PubMed 文献 · Blood · 2026-01-01

研究识别乳铁蛋白为凝血因子XIa(FXIa)活性增强剂,孕妇血浆乳铁蛋白浓度升高且呈雌激素依赖性,由乳铁蛋白基因启动子内雌激素反应元件(ERE)介导。小鼠模型中,乳铁蛋白基因敲除或HS9(1 mg/kg)阻断可改善妊娠诱导的血栓病理,HS9出血倾向低于低分子量肝素。

要点

  • 乳铁蛋白增强FXIa活性,孕妇血浆乳铁蛋白升高且受雌激素调控。
  • 小鼠中乳铁蛋白敲除或HS9(1 mg/kg)减轻妊娠诱导的血栓病理。
  • HS9(1 mg/kg)出血倾向低于低分子量肝素。

核心结论

  • 乳铁蛋白是妊娠期高凝状态的生理调节因子,并可能是妊娠相关静脉血栓栓塞症(VTE)的潜在治疗靶点,能在降低血栓风险的同时保护止血完整性。

研究设计与样本

  • 研究检测乳铁蛋白对凝血因子XIa(FXIa)活性的增强作用,观察孕妇血浆乳铁蛋白浓度及雌激素依赖性,并在小鼠模型中采用乳铁蛋白基因敲除或HS9(1 mg/kg)阻断进行干预。

主要发现

  • 孕妇血浆乳铁蛋白浓度升高,且呈雌激素依赖性,由乳铁蛋白基因启动子内的雌激素反应元件(ERE)介导。
  • 小鼠模型中,乳铁蛋白基因敲除或HS9(1 mg/kg)选择性抑制乳铁蛋白介导的FXIa增强,均可改善妊娠诱导的血栓病理。
  • HS9(1 mg/kg)相比低分子量肝素表现出显著降低的出血倾向。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE) remains a leading contributor to maternal morbidity and mortality during pregnancy and the immediate postpartum period. Although pregnancy is recognized as a hypercoagulable state, the molecular mechanisms underlying this prothrombotic shift remain incompletely characterized. In this study, lactoferrin was identified as an enhancer of coagulation factor XIa (FXIa) activity. Elevated plasma concentrations of lactoferrin were observed in pregnant women and found to be estrogen dependent, mediated through estrogen response elements (EREs) within the lactoferrin gene promoter. In murine models, pregnancy-induced thrombotic pathology was ameliorated by either genetic knockout of lactoferrin or pharmacological blockade using HS9, a peptide that selectively inhibits lactoferrin-mediated potentiation of FXIa. Notably, HS9 (1 mg/kg) exhibited a substantially reduced hemorrhagic profile compared with low-molecular-weight heparin. These findings identify lactoferrin as a physiological modulator of gestational hypercoagulability and implicate it as a potential therapeutic target for pregnancy-associated VTE, with the capacity to reduce thrombotic risk while preserving hemostatic integrity.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Cheng R, Tang X, Huang X, et al. Estrogen upregulates lactoferrin to induce hypercoagulability for hemostatic protection during pregnancy. Blood. 2026. PMID: 41411144. doi:10.1182/blood.2025030270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。